our portfolio



Oncologie is developing innovative medicines for cancer patients around the world. Using cutting edge approaches to patient selection and clinical trial design, Oncologie is developing next-generation biologics and small molecules. Oncologie's portfolio covers the spectrum of the cancer immunology landscape. Their teams in Boston and Shanghai are working together to bring new therapies to patients.